Corbus Pharmaceuticals Holdings, Inc. (CRBP)
3.07
+0.21
(+7.34%)
USD |
NASDAQ |
Nov 06, 16:00
3.06
-0.01
(-0.33%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Total Long Term Debt (Quarterly) : 3.265M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.265M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.307M |
| June 30, 2025 | 0.761M |
| March 31, 2025 | 1.205M |
| December 31, 2024 | 1.633M |
| September 30, 2024 | 2.048M |
| June 30, 2024 | 13.28M |
| March 31, 2024 | 15.81M |
| December 31, 2023 | 19.45M |
| September 30, 2023 | 21.46M |
| June 30, 2023 | 22.36M |
| March 31, 2023 | 23.52M |
| December 31, 2022 | 23.81M |
| September 30, 2022 | 24.28M |
| June 30, 2022 | 24.53M |
| March 31, 2022 | 25.00M |
| December 31, 2021 | 25.45M |
| September 30, 2021 | 24.80M |
| June 30, 2021 | 25.02M |
| March 31, 2021 | 25.43M |
| December 31, 2020 | 25.83M |
| September 30, 2020 | 25.21M |
| June 30, 2020 | 7.718M |
| Date | Value |
|---|---|
| March 31, 2020 | 8.292M |
| December 31, 2019 | 8.850M |
| September 30, 2019 | 7.940M |
| June 30, 2019 | 7.407M |
| March 31, 2019 | 7.299M |
| December 31, 2018 | 0.3947M |
| September 30, 2018 | 0.0015M |
| June 30, 2018 | 0.0863M |
| March 31, 2018 | 0.2123M |
| December 31, 2017 | 0.3375M |
| September 30, 2017 | 0.0056M |
| June 30, 2017 | 0.0457M |
| March 31, 2017 | 0.1633M |
| December 31, 2016 | 0.2802M |
| September 30, 2016 | 0.0091M |
| June 30, 2016 | 0.0333M |
| March 31, 2016 | 0.1049M |
| December 31, 2015 | 0.162M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.0725M |
| December 31, 2014 | 0.1444M |
| September 30, 2014 | 0.0752M |
| June 30, 2014 | 0.6385M |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 148.15M |
| Tonix Pharmaceuticals Holding Corp. | 1.022M |
| Karyopharm Therapeutics, Inc. | 255.12M |
| Minerva Neurosciences, Inc. | 71.74M |
| Ocugen, Inc. | 4.599M |